Kenawy Dahlia M, Stafford Jordan F, Amari Foued, Campbell Drayson, Abdel-Rasoul Mahmoud, Leight Jennifer, Chun Youngjae, Tillman Bryan W
Division of Vascular Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
College of Medicine, The Ohio State University, Columbus, OH.
JVS Vasc Sci. 2024 Jul 2;5:100212. doi: 10.1016/j.jvssci.2024.100212. eCollection 2024.
Aneurysm pathophysiology remains poorly understood, in part from the disparity of murine models with human physiology and the requirement for invasive aortic exposure to apply agents used to create aneurysm models. A retrievable drug infusion stent graft (RDIS) was developed to isolate the aortic wall intraluminally for drug exposure. We hypothesized that an RDIS could deliver aneurysm-promoting enzymes to create a porcine model of thoracic aneurysms without major surgical exposure.
Retrievable nitinol stent graft frames were designed with an isolated drug delivery chamber, covered with polytetrafluoroethylene, and connected to a delivery wire with a drug infusion catheter installed to the outer chamber. Institutional Animal Care and Use Committee-approved Yorkshire pigs (n = 5) underwent percutaneous access of the femoral artery, baseline aortogram and stent placement in the thoracic aorta followed by 30-minute exposure to a cocktail of elastase, collagenase, and trypsin. After aspiration of excess drug, stent retrieval, and femoral artery repair, animals were recovered, with angiograms at 1 and 4 weeks followed by explant. Histological analysis, in situ zymography, and multiplex cytokine assays were performed.
The RDIS isolated a segment of anterior aorta angiographically, while the center lumen preserved distal perfusion during drug treatment (baseline femoral mean arterial pressure, 70 ± 14 mm Hg; after RDIS, 75 ± 12; = .55). Endovascular induction of thoracic aneurysms did not require prior mechanical injury and animals revealed no evidence of toxicity. Within 1 week, significant aneurysmal growth was observed in all five animals (1.4 ± 0.1 cm baseline to 2.9 ± 0.7 cm; = .002) and only within the treated region of the aorta. Aneurysms persisted out to 4 weeks. Aneurysm histology demonstrated loss of elastin and collagen that was otherwise preserved in untreated aorta. Proinflammatory cytokines and increased matrix metalloproteinase activity were increased significantly within the aneurysm.
An RDIS achieves isolated drug delivery while preserving distal perfusion to achieve an endovascular porcine model of thoracic aneurysms without major surgery. This model may have value for surgical training, device testing, and to better understand aneurysm pathogenesis. Most important, although the RDIS was used to simulate aortic pathology, this tool offers intriguing horizons for focused therapeutic drug delivery directly to aneurysms and, more broadly, focused locoregional drug delivery to vessels and vascular beds.
动脉瘤的病理生理学仍未被充分理解,部分原因在于小鼠模型与人体生理学存在差异,且创建动脉瘤模型时需要通过侵入性主动脉暴露来应用相关药物。我们研发了一种可回收药物输注支架移植物(RDIS),用于在管腔内隔离主动脉壁以进行药物暴露。我们假设RDIS能够输送促进动脉瘤形成的酶,从而在不进行大型手术暴露的情况下创建猪胸主动脉瘤模型。
可回收的镍钛合金支架移植物框架设计有一个独立的药物输送腔,表面覆盖聚四氟乙烯,并通过安装在外腔的药物输注导管连接到输送导丝。经机构动物护理和使用委员会批准,对5只约克夏猪进行股动脉经皮穿刺、基线主动脉造影以及在胸主动脉放置支架,随后使其暴露于弹性蛋白酶、胶原酶和胰蛋白酶混合液中30分钟。抽吸多余药物、取出支架并修复股动脉后,让动物恢复,在1周和4周时进行血管造影,之后进行取材。进行组织学分析、原位酶谱分析和多重细胞因子检测。
RDIS在血管造影上隔离了一段胸主动脉前部,在药物治疗期间中心管腔保持远端灌注(基线股动脉平均动脉压为70±14mmHg;放置RDIS后为75±12;P = 0.55)。胸主动脉瘤的血管内诱导不需要预先的机械损伤,且动物未显示出毒性迹象。在1周内,所有5只动物均观察到显著的动脉瘤生长(基线时为1.4±0.1cm,至2.9±0.7cm;P = 0.002),且仅在主动脉的治疗区域内。动脉瘤持续存在至4周。动脉瘤组织学显示弹性蛋白和胶原蛋白丢失,而在未治疗的主动脉中这些成分得以保留。动脉瘤内促炎细胞因子和基质金属蛋白酶活性显著增加。
RDIS在保留远端灌注的同时实现了隔离药物输送,从而在不进行大型手术的情况下创建了猪胸主动脉瘤血管内模型。该模型可能在手术训练、器械测试以及更好地理解动脉瘤发病机制方面具有价值。最重要的是,尽管RDIS被用于模拟主动脉病变,但该工具为直接向动脉瘤进行聚焦治疗性药物输送,更广泛地说,为向血管和血管床进行聚焦局部药物输送提供了引人关注的前景。